Study Group 1 for Retinitis Pigmentosa
This trial is looking at the effects of different mutations that cause Retinitis Pigmentosa, a degenerative disease of the retina.
- Retinitis Pigmentosa
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What ultimate goal is this medical research aiming to attain?
"This clinical study, lasting approximately 12 months, will measure the progression of disease over time through Fundus Autofluorescence (FAF), Dark Adaptometry (DA) refraction and visual acuity using ETDRS or Snellen scales as well as Full-field Stimulus Thresholds (FST)."
Is this experiment still recruiting participants?
"According to clinicaltrials.gov, this particular medical study is not currently recruiting participants; the trial was initially posted on February 12th 2020 and last updated on April 19th 2022. Despite this fact, there are 51 other research initiatives that are actively enrolling patients at present."